Cargando…
Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy
A highly oxidized form of a chitosan/dextran-based hydrogel (CD-100) containing 80% oxidized dextran aldehyde (DA-100) was developed as a post-operative aid, and found to significantly prevent adhesion formation in endoscopic sinus surgery (ESS). However, the CD-100 hydrogel showed moderate in vitro...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490524/ https://www.ncbi.nlm.nih.gov/pubmed/26086827 http://dx.doi.org/10.3390/ijms160613798 |
_version_ | 1782379523157786624 |
---|---|
author | Chan, Maggie Brooks, Heather J. L. Moratti, Stephen C. Hanton, Lyall R. Cabral, Jaydee D. |
author_facet | Chan, Maggie Brooks, Heather J. L. Moratti, Stephen C. Hanton, Lyall R. Cabral, Jaydee D. |
author_sort | Chan, Maggie |
collection | PubMed |
description | A highly oxidized form of a chitosan/dextran-based hydrogel (CD-100) containing 80% oxidized dextran aldehyde (DA-100) was developed as a post-operative aid, and found to significantly prevent adhesion formation in endoscopic sinus surgery (ESS). However, the CD-100 hydrogel showed moderate in vitro cytotoxicity to mammalian cell lines, with the DA-100 found to be the cytotoxic component. In order to extend the use of the hydrogel to abdominal surgeries, reformulation using a lower oxidized DA (DA-25) was pursued. The aim of the present study was to compare the antimicrobial efficacy, in vitro biocompatibility and wound healing capacity of the highly oxidized CD-100 hydrogel with the CD-25 hydrogel. Antimicrobial studies were performed against a range of clinically relevant abdominal microorganisms using the micro-broth dilution method. Biocompatibility testing using human dermal fibroblasts was assessed via a tetrazolium reduction assay (MTT) and a wound healing model. In contrast to the original DA-100 formulation, DA-25 was found to be non-cytotoxic, and showed no overall impairment of cell migration, with wound closure occurring at 72 h. However, the lower oxidation level negatively affected the antimicrobial efficacy of the hydrogel (CD-25). Although the CD-25 hydrogel’s antimicrobial efficacy and anti-fibroblast activity is decreased when compared to the original CD-100 hydrogel formulation, previous in vivo studies show that the CD-25 hydrogel remains an effective, biocompatible barrier agent in the prevention of postoperative adhesions. |
format | Online Article Text |
id | pubmed-4490524 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-44905242015-07-07 Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy Chan, Maggie Brooks, Heather J. L. Moratti, Stephen C. Hanton, Lyall R. Cabral, Jaydee D. Int J Mol Sci Article A highly oxidized form of a chitosan/dextran-based hydrogel (CD-100) containing 80% oxidized dextran aldehyde (DA-100) was developed as a post-operative aid, and found to significantly prevent adhesion formation in endoscopic sinus surgery (ESS). However, the CD-100 hydrogel showed moderate in vitro cytotoxicity to mammalian cell lines, with the DA-100 found to be the cytotoxic component. In order to extend the use of the hydrogel to abdominal surgeries, reformulation using a lower oxidized DA (DA-25) was pursued. The aim of the present study was to compare the antimicrobial efficacy, in vitro biocompatibility and wound healing capacity of the highly oxidized CD-100 hydrogel with the CD-25 hydrogel. Antimicrobial studies were performed against a range of clinically relevant abdominal microorganisms using the micro-broth dilution method. Biocompatibility testing using human dermal fibroblasts was assessed via a tetrazolium reduction assay (MTT) and a wound healing model. In contrast to the original DA-100 formulation, DA-25 was found to be non-cytotoxic, and showed no overall impairment of cell migration, with wound closure occurring at 72 h. However, the lower oxidation level negatively affected the antimicrobial efficacy of the hydrogel (CD-25). Although the CD-25 hydrogel’s antimicrobial efficacy and anti-fibroblast activity is decreased when compared to the original CD-100 hydrogel formulation, previous in vivo studies show that the CD-25 hydrogel remains an effective, biocompatible barrier agent in the prevention of postoperative adhesions. MDPI 2015-06-16 /pmc/articles/PMC4490524/ /pubmed/26086827 http://dx.doi.org/10.3390/ijms160613798 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chan, Maggie Brooks, Heather J. L. Moratti, Stephen C. Hanton, Lyall R. Cabral, Jaydee D. Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy |
title | Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy |
title_full | Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy |
title_fullStr | Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy |
title_full_unstemmed | Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy |
title_short | Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy |
title_sort | reducing the oxidation level of dextran aldehyde in a chitosan/dextran-based surgical hydrogel increases biocompatibility and decreases antimicrobial efficacy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490524/ https://www.ncbi.nlm.nih.gov/pubmed/26086827 http://dx.doi.org/10.3390/ijms160613798 |
work_keys_str_mv | AT chanmaggie reducingtheoxidationlevelofdextranaldehydeinachitosandextranbasedsurgicalhydrogelincreasesbiocompatibilityanddecreasesantimicrobialefficacy AT brooksheatherjl reducingtheoxidationlevelofdextranaldehydeinachitosandextranbasedsurgicalhydrogelincreasesbiocompatibilityanddecreasesantimicrobialefficacy AT morattistephenc reducingtheoxidationlevelofdextranaldehydeinachitosandextranbasedsurgicalhydrogelincreasesbiocompatibilityanddecreasesantimicrobialefficacy AT hantonlyallr reducingtheoxidationlevelofdextranaldehydeinachitosandextranbasedsurgicalhydrogelincreasesbiocompatibilityanddecreasesantimicrobialefficacy AT cabraljaydeed reducingtheoxidationlevelofdextranaldehydeinachitosandextranbasedsurgicalhydrogelincreasesbiocompatibilityanddecreasesantimicrobialefficacy |